ChemicalBook > Product Catalog >API >Circulatory system drugs >Angina Pectoris Drugs >Naftopidil DiHCl

Naftopidil DiHCl

Naftopidil DiHCl Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Tel: 18930552037
Email: 3bsc@sina.com
Company Name: Pure Chemistry Scientific Inc.  
Tel: 001-857-928-2050 or 1-888-588-9418
Email: sales@chemreagents.com
Company Name: Chemsky(shanghai)International Co.,Ltd.  
Tel: 021-50135380
Email: shchemsky@sina.com
Company Name: BioBioPha Co., Ltd.  
Tel: 0871-65217109
Email: y.liu@mail.biobiopha.com

Naftopidil DiHCl manufacturers

  • Naftopidil
  • Naftopidil pictures
  • $1.00
  • 2020-01-13
  • CAS:57149-08-3
  • Min. Order: 1g
  • Purity: 99%
  • Supply Ability: 1ton
Naftopidil DiHCl Basic information
Product Name:Naftopidil DiHCl
Synonyms:NAFTOPIDIL 2HCL;4-(2-METHOXYPHENYL)-A-[(1-NAPHTHALENYLOXY)METHYL]-1-PIPERAZINEETHANOL, DIHYDROCHLORIDE;4-(2-METHOXYPHENYL)-ALPHA-([1-NAPHTHALENYLYOXY]METHYL)-1-PIPERAZINEETHANOL DIHYDROCHLORIDE;KT-611 DIHYDROCHLORIDE;4-(2-Methoxyphenyl)-a-[(1-naphthalenyloxy)methyl]-1-piperazineethanol,2HCl;Naftopidil HCL;3-[(4-methylpiperazin-1-yl)methyl]quinazolin-4-one dihydrochloride;1-[4-(2-Methoxyphenyl)-1-piperazinyl]-3-(1-naphthoxy)-2-propanol dihydrochloride
CAS:57149-08-3
MF:C24H30Cl2N2O3
MW:465.41
EINECS:200-258-5
Product Categories:Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Flivas, KT-611, Avishot
Mol File:57149-08-3.mol
Naftopidil DiHCl Structure
Naftopidil DiHCl Chemical Properties
Melting point 212-213°
storage temp. Sealed in dry,Room Temperature
solubility methanol: >10 mg/mL
form solid
color white
Safety Information
WGK Germany 3
RTECS TL9336500
MSDS Information
ProviderLanguage
SigmaAldrich English
Naftopidil DiHCl Usage And Synthesis
Chemical PropertiesOff-White Solid
UsesA α-1-Adrenergic receptor antagonist, antihypertensive.
UsesAntihypertensive;Alpha1 agonist
in vivo

Naftopidil dihydrochloride (10 mg/kg; p.o; daily; for 28 days) decreases microvessel density (MVD) in E9+PrSC tumors mice model[2].

Animal Model:Male athymic mice(7-8 weeks), with E9+PrSC xenograft[2]
Dosage:10 mg/kg
Administration:Oral administration, daily, for 28 days
Result:Decreased tumor weights.
IC 50Alpha-1A adrenergic receptor: 3.7 nM (Ki); Alpha-1B adrenergic receptor: 20 nM (Ki); Alpha-1D adrenergic receptor: 1.2 (Ki)
Naftopidil DiHCl Preparation Products And Raw materials
Tag:Naftopidil DiHCl(57149-08-3) Related Product Information
AR-13324 (mesylate) Phenylephrine Metoprolol Phosphorylcholine Mirabegron NADOLOL